George M. Milne Jr., Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 5,000 shares at $10.82 ($54K) on 2022-03-04, disclosed to the SEC on 2022-03-08.
Open-market purchase of $54k AUPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| AUPH | BUY | 2023-03-06 | $178K | — | Filing → |
| AMLX | BUY | 2022-01-10 | $500K | — | Filing → |
| AUPH | BUY | 2021-03-09 | $65K | — | Filing → |